These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7511758)

  • 41. Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival.
    Bastien NR; Juneau AV; Ouellette J; Lambert C
    Cardiovasc Res; 1999 Jul; 43(1):77-85. PubMed ID: 10536692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic alterations of quinapril during repeated treatment in elderly subjects.
    Sasaki M; Maeda A; Fujimura A
    Eur J Clin Pharmacol; 1998 Jun; 54(4):347-9. PubMed ID: 9696962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quinapril decreases renal endothelin-1 expression and synthesis in a normotensive model of immune-complex nephritis.
    Ruiz-Ortega M; Gómez-Garre D; Liu XH; Blanco J; Largo R; Egido J
    J Am Soc Nephrol; 1997 May; 8(5):756-68. PubMed ID: 9176845
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of two structurally different angiotensin-converting enzyme inhibitors, captopril and quinapril (CI-906), in rats with one-kidney deoxycorticosterone-salt hypertension.
    Pörsti I; Säynävälammi P; Arvola P; Nurmi AK; Manninen V; Ylitalo P; Vapaatalo H
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):543-6. PubMed ID: 3022083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between chronic converting enzyme inhibition and AT1 blockade in mRen2 transgenic rats.
    Lantelme P; Lo M; Mullins JJ; Gharib C; Bizollon CA; Sassard J
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):476-81. PubMed ID: 8847862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of enalapril and quinapril on forearm vascular ACE in man.
    Lyons D; Webster J; Benjamin N
    Eur J Clin Pharmacol; 1997; 51(5):373-8. PubMed ID: 9049577
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
    Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
    Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of renin-angiotensin system in mediating endothelin-induced renal vasoconstriction: therapeutic implications.
    Chan DP; Clavell A; Keiser J; Burnett JC
    J Hypertens Suppl; 1994 Jul; 12(4):S43-9. PubMed ID: 7965274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic ACE inhibition by quinapril modulates central vasopressinergic system.
    Muders F; Elsner D; Jandeleit K; Bahner U; Kromer EP; Kirst I; Riegger GA; Palkovits M
    Cardiovasc Res; 1997 Jun; 34(3):575-81. PubMed ID: 9231041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adverse effects of angiotensin-converting enzyme inhibitors in antihypertensive therapy with focus on quinapril.
    Materson BJ
    Am J Cardiol; 1992 Apr; 69(10):46C-53C. PubMed ID: 1546639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
    Keuneke C; Yacullo R; Metzger R; Hellmann T; Peters J; Ganten D
    Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo kinetics of indoxyl sulfate in humans and its renal interaction with angiotensin-converting enzyme inhibitor quinapril in rats.
    Fujita T; Ishihara K; Yasuda S; Nakamura T; Maeda M; Kobayashi M; Sahashi K; Ikeda Y; Kumagai Y; Majima M
    J Pharmacol Exp Ther; 2012 Jun; 341(3):626-33. PubMed ID: 22389425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
    Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
    Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
    Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
    Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of arterial thrombogenesis by quinapril but not losartan.
    Bavry AA; Li D; Zander DS; Phillips MI; Mehta JL
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):121-7. PubMed ID: 11150391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Which urinary proteins are decreased after angiotensin converting--enzyme inhibition?
    Guidi E; Giglioni A; Cozzi MG; Minetti EE
    Ren Fail; 1998 Mar; 20(2):243-8. PubMed ID: 9574449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.